Stay updated on Safety Tolerance Efficacy in IPF Clinical Trial
Sign up to get notified when there's something new on the Safety Tolerance Efficacy in IPF Clinical Trial page.

Latest updates to the Safety Tolerance Efficacy in IPF Clinical Trial page
- CheckyesterdayChange DetectedA site-wide NIH notice announces a terminology transition from “Artificial Intelligence” to “Super Intelligence.” It appears above the 403 error page instead of study details.SummaryDifference1%

- Check8 days agoChange DetectedThe footer revision identifier was updated from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check15 days agoChange DetectedThe ClinicalTrials.gov site revision changes from v3.7.0 to v3.7.1; the page continues to show an access-denied error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record content, effectively blocking access to the study details.SummaryDifference17%

- Check57 days agoChange DetectedThe page now displays a newer revision label (v3.6.6) replacing the previous v3.6.5, indicating a version update to the study record. This change is primarily administrative and does not alter how the study operates or its data.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page shows Revision: v3.6.5, indicating a small platform update; the change does not appear to affect study details or how information is presented.SummaryDifference0.1%

Stay in the know with updates to Safety Tolerance Efficacy in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Tolerance Efficacy in IPF Clinical Trial page.